Abdominal organ injury after cardiac surgery

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 8, Issue 3, 2004, Pages 243-263

  Hessel II, Eugene A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN; AMRINONE; ANTIINFLAMMATORY AGENT; APROTININ; C REACTIVE PROTEIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ENDOTOXIN; FENOLDOPAM; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INTERLEUKIN 6; LOPRINONE; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; POLYMYXIN; PREDNISOLONE; SERUM AMYLOID A; STEROID; TOBRAMYCIN; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ABDOMINAL INJURY; ACUTE CHOLECYSTITIS; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG UTILIZATION; GASTROINTESTINAL DISEASE; HEART OUTPUT; HEART SURGERY; HUMAN; INCIDENCE; INTESTINE ISCHEMIA; INTESTINE PERFUSION; LIVER BLOOD FLOW; LIVER FAILURE; MICROCIRCULATION; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN TRANSPORT; PANCREATITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTOR; SPLANCHNIC BLOOD FLOW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOEMBOLISM; UPPER GASTROINTESTINAL BLEEDING;

ABDOMEN; ANIMALS; CARDIAC SURGICAL PROCEDURES; CHOLECYSTITIS; GASTROINTESTINAL DISEASES; HUMANS; LIVER FAILURE; POSTOPERATIVE COMPLICATIONS;

EID: 5044235813     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320400800306     Document Type: Conference Paper

References (188)

1. Vijay V, Gold JP: Late complications of cardiac surgery. Chap 18 in Cohn LH and Edmunds LH, Jr. Cardiac Surgery in the Adult. 2nd Ed. McGraw-Hill, New York, pp. 521-537, 2003.
2. Shangraw RE: Splanchnic, hepatic and visceral effects. Chap. 20 in Gravelee GP, Davis RF, Kurusz M, Utley JR. Cardiopulmonary Bypass, 2nd Ed. Phila, Lippincott, William & Wilkins, pp. 391-402, 2000.
3. Sakorafas GH, Tsiotos ES: Intra-abdominal complications after cardiac surgery. Eur J Surg 165:820-827, 1999.
4. Halm MA: Acute gastrointestinal complications after cardiac surgery. Am J Crit Care 5:109-118, 1996.
5. Lawhorne TW Jr, Davis JL, Smith GW: General surgical complications after cardiac surgery. Am J Surg 136:254-256, 1976.
6. Wallwork KJ, Davidson KG: The acute abdomen following cardiopulmonary bypass surgery. Br J Surg 67:410-412, 1980.
7. Lucas A, Max MH: Emergency laparotomy immediately after coronary bypass. JAMA 244:1829-1831, 1980.
8. Hanks JB, Curtis SE, Hanks BB, et al: Gastrointestinal complications after cardiopulmonary bypass. Surgery 92:394-400, 1982.
9. Birken GA, Cooperman M, Carey LC: Abdominal complications necessitating operative intervention after thoracic operations. Curr Surg 39:40-41, 1982.
10. Reath DB, Maull KI, Wolfgan TC: General surgical complications following cardiac surgery. Am Surg 49:11-14, 1983.
11. Pinson CW, Alberty RE: General surgical complications after cardiopulmonary bypass. Am J Surg 146:133-137, 1983.
12. Aranha GV, Pickleman J, Pifarre R, et al: The reasons for gastrointestinal consultation after cardiac surgery. Am Surg 50:301-304, 1984.
13. Moneta GL, Misbach GA, Ivey TD: Hypoperfusion as a possible factor in the development of gastrointestinal complications after cardiac surgery. Am J Surg 149:648-650, 1985.
14. Welling RE, Rath R, Albers JE, et al: Gastrointestinal complications after cardiac surgery. Arch Surg 121:1178-1180, 1986.
15. Heikkenen LO, Ala-Kulju KV: Abdominal complications following cardiopulmonary bypass in open-heart surgery. Scand J Thorac Cardiovasc Surg 21:1-7, 1987.
16. Leitman IM, Paull de, Barie PS, et al: Intra-abdominal complications of cardiopulmonary bypass operations. Surg Gynecol Obst 165:251-254, 1987.
17. Krasna MJ, Flanchbaum L, Trooskin SZ, et al: Gastrointestinal complications after cardiac surgery. Surgery 104:773-780, 1988.
18. Rosemurgy AS, McAllister E, Karl RC: The acute surgical abdomen after cardiac surgery involving extracorporeal circulation. Ann Surg 207:323-326, 1988.
19. Ohri SK, Desai JB, Gaer JAR, et al: Intra-abdominal complications after cardiopulmonary bypass. Ann Thorac Surg 52:826-831, 1991.
20. Huddy SDJ, Joyce WP, Pepper JR: Gastrointestinal complications in 4473 patients who underwent cardiopulmonary bypass surgery. Br J Surg 78:293-296, 1991.
21. Johnston G, Vitikainen K, Knight R, et al: Changing perspective on gastrointestinal complications in patients undergoing cardiac surgery. Am J Surg 163:525-529, 1992.
22. Egleston CV, Gorey TF, Wood AE, et al: Gastrointestinal complications after cardiac surgery. Ann Royal Coll Surg Engl 75:52-56, 1993.
23. Christenson JT, Schmuziger M, Maurice J, et al: Gastrointestinal complications after coronary artery bypass grafting. J Thorac Cardiovasc Surg 108:899-906, 1994.
24. Tsiotos GG, Mullany CJ, Zietlows S, et al: Abdominal complications following cardiac surgery. Am J Surg 167:553-557, 1994.
25. Mercado PD, Farid H, O'Connell TX, et al: Gastrointestinal complications associated with cardiopulmonary bypass procedures. Am Surg 60:789-792, 1994.
26. Spotnitz WD, Sanders RP, Hanks JB, et al: General surgical complications can be predicted after cardiopulmonary bypass. Ann Surg 221:489-497, 1995.
27. Landow L, Andersen LW: Splanchnic ischemia and its role in multiple organ failure. Acta Anaesth Scan 38:626-639, 1994.
28. Ott MJ, Buchman TG, Baumgartner WA: Postoperative abdominal complications in cardiopulmonary bypass patients: A case-controlled study. Ann Thorac Surg 59:1210-1213, 1995.
29. Yilmaz AT, Arslan M, Demirkilic U, et al: Gastrointestinal complications after cardiac surgery. Eur J Cardiothorac Surg 10:763-767, 1996.
30. Perugini RA, Orr RK, Porter D, et al: Gastrointestinal complications following cardiac surgery. Arch Surg 132:352-357, 1997.
31. Simic O, Strathausen S, Hess W, et al: Incidence and prognosis of abdominal complications after cardio-pulmonary bypass. Cardiovasc Surg 7:419-424, 1999.
32. Aouifi A, Piriou V, Bastien O, et al: Complications digestives severes après chirurgie cardiaque sous circulation extracoporelle. Can J Anesth 46:114-121, 1999.
33. Fitzgerald T, Kim D, Karakozis S, et al: Visceral ischemia after cardiopulmonary bypass. Am Surg 66:623-626, 2000.
34. Akpinar B, Sagbas E, Guden M, et al: Acute gastrointestinal complications after open heart surgery. Asian Cardiovasc Thorac Ann 8:109-113, 2000.
35. Zacharias A, Schwann TA, Parenteau GL, et al: Predictors of gastrointestinal complications in cardiac surgery. Texas Heart Inst J 27:93-99, 2000.
36. Byhahn C, Strouhal U, Martens S, et al: Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg 25:1140-1144, 2001.
37. Ghosh S, Roberts N, Firmin RK, et al: Risk factors for intestinal ischemia in cardiac surgical patients. Eur J Cardio-thorac Surg 21:411-416, 2002.
38. Musleh GS, Patel NC, Grayson AD, et al: Off-pump coronary artery bypass surgery does not reduce gastrointestinal complications. Eur J Cardio-Thorac Surg 23:170-174, 2003.
39. D'Ancona G, Baillot R, Poirier B, et al: Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30:280-285, 2003.
40. Sanisoglu I, Guden M, Bayramoglu Z, et al: Does off-pump CABG reduce gastrointestinal complications? Ann Thorac Surg 77:619-625, 2004.
41. McSweeney ME, Garwood S, Levin J, et al: Adverse gastrointestinal complications after cardiopulmonary bypass: Can outcome be predicted from preoperative risk factors? Anesth Analg 98:1610-1617, 2004.
42. Cates J, Chavez M, Laks H, et al: Gastrointestinal complications after cardiac transplantation: A spectrum of diseases. Am J Gastroint 86:412-416, 1991.
43. Blauth CI, Cosgrove DM, Webb BW, et al: Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 103:1104-1112, 1992.
44. Doty JR, Wilentz RE, Salazar JD, et al: Atheroembolism in cardiac surgery. Ann Thorac Surg 75:1221-1226, 2003.
45. Cetindag I, Boley TM, Magee MJ, Hazelrigg SR. Postoperative gastrointestinal complications after lung volume reduction operations. Ann Thorac Surg 68:1029-1033, 1999.
46. Smith PC, Slaughter MS, Petty MG, et al: Abdominal complications after lung transplantation. J Heart Lung Transpl 14:44-51, 1995.
47. Mutlu GM, Mutlu EA, Factor P: GI complications in patients receiving mechanical ventilation. Chest 119:1222-1241, 2001.
48. Elizalde JI, Hernandez C, Llach J, et al: Gastric intramucosal acidosis in mechanically ventilated patients. Crit Care Med 26:827-832, 1998.
49. Canver CC, Chanda J: Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg 75:853-857, 2003.
50. Van der Voort PHJ, Zandstra DF: Pathogenesis, risk factors and incidence of upper gastrointestinal bleeding after cardiac surgery: Is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth 14:293-299, 2000.
51. Rosen HC, Vlahakes GJ, Rattner DW: Fulminant peptic ulcer disease in cardiac surgical patients: Pathogenesis, prevention and management. Crit Care Med 20:354-359, 1992.
52. Hass GS, Warshaw AL, Daggett WM, et al: Acute pancreatitis after cardiopulmonary bypass. Am J Surg 149:508-515, 1985.
53. del Castillo CF, Harringer W, Warshaw AL, et al: Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 325:382-387, 1991.
54. Lefor AT, Vuocolo P, Parker FB Jr, et al: Pancreatic complications following cardiopulmonary bypass. Arch Surg 127:1225-1230, 1992.
55. Herline AJ, Pinson CW, Wright JK, et al: Acute pancreatitis after cardiac transplantation and other cardiac procedures: Case control analysis in 24,631 patients. Am Surg 65:819-826, 1999.
56. Rattner DW, Gu Z-Y, Vlahakes GJ, et al: Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 209:279-283, 1989.
57. Tikanoja T, Rautiainen P, Leijala M, et al: Hyperamylasemia after cardiac surgery in infants and children. Intensive Care Med 22:949-963, 1996.
58. Ihaya A, Muroaka R, Chiba Y, et al: Hyperamylasemia and subclinical pancreatitis after cardiac surgery. World J Surg 25:862-864, 2001.
59. Syed AU, Border WL, Michenfelder EC, et al: Pancreatitis in Fontan patients is related to impaired ventricular relaxation. Ann Thorac Surg 75:153-157, 2003.
60. Venkafeswaran JV, Charman SC, Goddard M, et al: Lethal mesenteric ischemia after cardiopulmonary bypass: A common complication? Eur J Cardiothorac Surg 22:534-538, 2002.
61. Garofalo M, Borioni R, Nardi P, et al: Early diagnosis of acute mesenteric ischemia after cardiopulmonary bypass. J Cardiovasc Surg 43:455-459, 2002.
62. Klotz S, Vesting T, Rotker J, et al: Diagnosis and treatment of non-occlusive mesenteric ischemia after open heart surgery. Ann Thorac Surg 72:1583-1586, 2001.
63. Klempnauer J, Grothues F, Bektas H, et al: Acute mesenteric ischemia following cardiac surgery. J Cardiovasc Surg 38:639-643, 1997.
64. Gennaro M, Ascer E, Matano R, et al: Acute mesenteric ischemia after cardiopulmonary bypass. Am J Surg 166:231-236, 1993.
65. Allen KB, Salam AA, Lumsden A-B: Acute mesenteric ischemia after cardiopulmonary bypass. J Vasc Surg 16:391-396, 1992.
66. Albes JM, Schistek R, Baler R, et al: Intestinal ischemia associated with cardio-pulmonary-bypass surgery: A life threatening complication. J Cardiovasc Surg 32:527-533, 1991.
67. Burns BJ, Brandt LJ: Intestinal ischemia. Gastroenterol Clin North Am 32:1127-1143, 2003.
68. Lock G: Acute mesenteric ischemia: Classification, evaluation, and therapy. Acta Gastro-enterol Belg 65:220-225, 2002.
69. Biraima AM, Genoni M, Winkler MB, et al: Mesenteric ischemia after a cardiac operation: Atherosclerotic versus vasospastic etiology. J Cardiovasc Surg 43:87-89, 2002.
70. Niederhauser U, Genoni M, von Segesser K, et al: Mesenteric ischemia after cardiac operstions: Conservative treatment with local vasodilation Ann Thorac Surg 61:1817-1819, 1996.
71. Sessions SC, Scoma RS, Sheikh FA, et al: Acute acalculous cholecystitis following open heart surgery. Am Surg 59:74-77, 1993.
72. Collins JD, Bassendine MF, Ferner R, et al: Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 21:1119-1123, 1983.
73. Ryan TA, Rady MY, Bashear A, et al: Predictors of outcome in cardiac surgery patients with prolonged intensive care stay. Chest 112:1035-1042, 1997.
74. Michalopoulos A, Alivizatos P, Geroulanos S: Hepatic dysfunction following cardiac surgery: Determinants and consequences. Hepato- Gastroenterology 44:779-783, 1997.
75. Takeda M, Furuse A, Kawauchi M, et al: Estimation of functional liver reserve in patients before cardiac surgery using antipyrine plasma clearance test. J Cardiovasc Surg 40:817-823, 1999.
76. Raman JS, Kochi K, Morimatsu H, et al: Severe ischemic early liver injury following cardiac surgery. Ann Thorac Surg 74:1601-1606, 2002.
77. Seeto RK, Fenn B, Rockey DC: Ischemic hepatitis: Clinical presentation and pathogenesis. Am J Med 109:109-113, 2000.
78. Henrion J, Descamps O, Luwaert R, et al: Hypoxic hepatitis in patients with cardiac failure: Incidence in a coronary care unit and measurements of hepatic blood flow. J Hepatology 21:696-703, 1994.
79. Hayashida N, Shoujima T, Teshima H, et al: Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg 77:500-505, 2004.
80. Kaplan M, Cimen S, Kut MS, et al: Cardiac operations for patients with chronic liver disease. Heart Surg Forum 5:60-65, 2002.
81. Ninomiya M, Takamoto S, Kotsuka Y, et al: Indication and perioperative management for cardiac surgery in patients with liver cirrhosis. Jap J Thorac Cardiovasc Surg 49:391-394, 2001.
82. Bizouarn P, Ausseur A, Desseigne P, et al: Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 67:1334-1338, 1999.
83. Ziser A, Plevak DJ, Wiesner RH, et al: Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90:42-53, 1999.
84. Klemperer JD, Ko W, Krieger KH, et al: Cardiac operations in patients with cirrhosis. Ann Thorac Surg 65:85-87, 1998.
85. Watanabe Y, Kumon K: Assessment by pulse dye-densitometry indocyanine green clearance test of hepatic function in patients before cardiac surgery: Its value as a predictor of serious postoperative liver dysfunction. J Cardiothorac Vasc Anesth 13:299-303, 1999.
86. Takala J: Determinants of splanchnic blood flow. Br J Anaesth 77:50-58, 1996.
87. Ackland G, Grocott MPW, Mythen MG: Understanding gastrointestinal perfusion in critical care: So near and yet so far. Crit Care 4:269-281, 2000.
88. Matheson PJ, Wilson MA, Garrison RN: Regulation of intestinal blood flow (Research review). J Surg Research 93:182-196, 2000.
89. Reilly PM, Bulkley GB: Vasoactive mediators and splanchnic perfusion. Crit Care Med 21:S-55-S-68, 1993.
90. Pannen BHJ: New insights into the regulation of hepatic blood flow after ischemia and reperfusion (Review). Anesth Analg 94:1448-1457, 2002.
91. Jakob SM: Splanchnic blood flow in low-flow states. Anesth Analg 96:1129-1138, 2003.
92. Gelman S, Mushlin PS: Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. Anesthesiology 1000:434-439, 2004.
93. Mathie RT: Hepatic blood flow during cardiopulmonary bypass. Crit Care Med 21:S72-76, 1993.
94. Landow L: Splanchnic lactate production in cardiac surgery. Crit Care Med 21:584-589, 1993.
95. Chapman MV, Woolf RL, Bennett-Guerrero E, et al: The effect of hypothermia on calculated values using saline and automated air tonometry. J Cardiothorac Vasc Anesth 16:304-307, 2002.
96. Chapman MV, Mythen MG, Webb AR, et al: Report from the meeting: Gastrointestinal tonometry: State-of-the-art. Int Care Med 26:613-622, 2000.
97. Bennett-Guerro E, Pandh MH, Bodian CA, et al: Automated detection of gastric luminal partial pressure of carbon dioxide during cardiovascular surgery using the Tonocap. Anesthesiology 92:38-45, 2000.
98. Marik P: Gastric tonometry. The Canary Sings Once Again. Crit Care Med 26:809-810, 1998.
99. Mythen MG, Webb AR: Gastrointestinal tonometry comes of age? (Editorial). Br J Anaesth 81:667-668, 1998.
100. Fiddian-Green R, Baker S: Predictive value of the stomach wall pH for complications after cardiac operations: Comparison with other monitoring. Crit Care Med 15:153-156, 1987.
101. Mythen MG, Webb AR: Intraoperative gut mucosal hypoperfusion is associated with increased postoperative complications and cost. Int Care Med 20:99-104, 1994.
102. Kavarana MN, Frumento RJ, Hirsch AL, et al: Gastric hypercarbia and adverse outcomes after cardiac surgery. Int Care Med 29:742-748, 2003.
103. Riddington DW, Venkatesh B, Boivin CM, et al: Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 275:1007-1012, 1996.
104. Bohrer IT, Schmidt H, Motsch J, et al: Gastric intramucosal pH: A predictor of survival in cardiac surgery patients with low cardiac output? J Cardiothorac Vasc Anesth 11:184-186, 1997.
105. Videm V, Svennevig JL, Fosse E, et al: Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis. Perfusion 15:421-426, 2000.
106. Uusaro A, Ruokonen E, Takala J: Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 74:149-154, 1995.
107. Walley KR, Friesen BP, Humer MF, et al: Small bowel tonometry is more accurate than gastric tonometry in detecting gut ischemia. J Appl Physiol 85:1770-1777, 1998.
108. Rudy LW, Heymann MA, Edmunds LH Jr: Distribution of systemic blood flow during cardiopulmonary bypass in the Rhesus monkey. Surg Forum 22:149-151, 1970.
109. Rudy LW, Heymann, MA, Edmunds LH Jr: Distribution of systemic blood flow during cardiopulmonary bypass. J Appl Physiol 34:194-200, 1973.
110. Lees MH, Herr RH, Hill JD, et al: Distribution of systemic blood flow of the Rhesus monkey during cardiopulmonary bypass. J Thorac Cardiovasc Surg 61:570-586, 1971.
111. Mathie RT, Desai JB, Taylor FM: The effect of normothermic cardiopulmonary bypass on hepatic blood flow in the dog. Perfusion 1:245-253, 1986.
112. Mori A, Watanabe K, Onoe M, et al: Regional blood flow in liver, pancreas, and kidney during pulsatile and non-pulsatile perfusion under profound hypothermia. Jap Circ J 52:219-227, 1988.
113. Slater JM, Orszulak TA, Cook DJ: Distribution and hierarchy of regional blood flow during hypothermic cardiopulmonary bypass. Ann Thorac Surg 72:542-547, 2001.
114. Boston US, Slater JM, Orszulak TA, et al: Hierarchy of regional oxygen delivery during cardiopulmonary bypass. Ann Thorac Surg 71:260-264, 2001.
115. Bastien O, Pirious V, Aouifi A, et al: Relative importance of flow versus pressure in splanchnic perfusion during cardiopulmonary bypass in rabbits. Anesthesiology 92:457-464, 2000.
116. Mackay JH, Feerick AE, Woodson LC, et al: Increasing organ blood flow during cardiopulmonary bypass in pigs: Comparison of dopamine and perfusion pressure. Crit Care Med 23:1090-1098, 1995.
117. Smith EEJ, Naftel DC, Blackstone EH, et al: Microvascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg 94:225-233, 1987.
118. Ohri SK, Becket J, Brannon J, et al: Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg 57:1193-1199, 1994.
119. Tao W, Zwichenberger JB, Nguyen TT, et al: Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 110:819-828, 1995.
120. Tofukuji M, Stahl GL, Metais C, et al: Mesenteric dysfunction after cardiopulmonary bypass: Role of compliment C5a. Ann Thorac Surg 69:799-807, 2000.
121. Haisjackl M, Germann R, Hasibeder W, et al: Mucosal tissue oxygenation of the porcine jejunum during normothermic cardiopulmonary bypass. Br J Anaesth 82:738-745, 1999.
122. Sack FU, Dollner R, Reidenbach B, et al. Extracorporeal circulation induced microvascular perfusion injury of the small bowel. Eur Surg Res 34:418-424, 2002.
123. Hampton WW, Townsend, MC, Schirmer WJ, et al: Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 124:458-459, 1989.
124. Haisjackl M, Birnbaum J, Redlin M, et al: Splanchnic oxygen transport and lactate metabolism during normothermic cardiopulmonary bypass in humans. Anesth Analg 86:22-27, 1998.
125. Okano N, Hiraoka H, Owada R, et al: Hepatosplanchnic oxygenation is better preserved during mild hypothermic than during normothermic cardiopulmonary bypass. Can J Anesth 48:1011-1014, 2001.
126. Okano N, Miyoshi S, Owada R, et al: Impairment of hepatosplanchnic oxygenation and increase of serum hyaluronte during normothermic and mild hypothermic cardiopulmonary bypass. Anesth Analg 95:278-286, 2002.
127. Gardenback M, Settergren G, Brodin L-A, et al: Splanchnic blood flow and oxygen uptake during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 16:308-315, 2002.
128. Ohri SK, Bjarnason I, Pathi V, et al: Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 55:1080-1086, 1993.
129. Gaer JAR, Shaw ADS, Wild R, et al: Effect of cardiopulmonary bypass on gastrointestinal perfusion and function. Ann Thorac Surg 57:371-375, 1994.
130. Ohri SK, Bowles CW, Mathie RT, et al: Effect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow. Ann Thorac Surg 94:163-170, 1997.
131. Thoren A, Elam M, Ricksten S-E: Jejunal mucosal perfusion is well maintained during mild hypothermic cardiopulmonary bypass in humans. Anesth Analgesia 92:5-11, 2001.
132. Jakob SM, Ruokonen E, Takala J: Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth 84:571-577, 2000.
133. Velissaris T, Tang A, Murray M, et al: A prospective randomized study to evaluate splanchnic hypoxia during beating-heart and conventional coronary revascularization. Eur J Cardio-thorac Surg 23:917-924, 2003.
134. Holmes JH, Lieberman JM, Probert CB, et al: Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass. A preliminary analysis. J Surg Res 100:192-196, 2001.
135. Uusaro A, Ruokonen E, Takala J: Splanchnic oxygen transport after cardiac surgery: Evidence for inadequate tissue perfusion after stabilization of hemodynamics. Int Care Med 22:26-33, 1996.
136. Niinikoski J, Kottila F: Adequacy of tissue oxygenation in cardiac surgery: Regional measurement. Crit Care Med 21:S77-S78, 1993.
137. Baue AE: The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg 55:822-829, 1993.
138. Lazar HL, Hudson H, McCann J, et al: Gastrointestinal complications following cardiac surgery. Cardiovasc Surg 3:341-344, 1995.
139. Biffl WL, Moore EE: Splanchnic ischemia/reperfusion and multiple organ failure. Br J Anaesth 77:59-70, 1996.
140. Aranow JS, Fink MP: Determinants of intestinal barrier failure in critical illness. Br J Anaesth 77:71-81, 1996.
141. Ohri SK: Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass. Perfusion 11:200-212, 1996.
142. Laffey JG, Boylan JF, Cheng DCH: The systemic inflammatory response to cardiac surgery. (Review) Anesthesiology 97:215-252, 2002.
143. Hill GE: The inflammatory response to cardiopulmonary bypass. Sem Cardiothorac Vasc Anesth 5:229-235, 2001.
144. Rocke DA, Gaffin SL, Wells MT, et al: Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93:832-837, 1987.
145. Jansen NJG, van Oeveren W, Gu YJ, et al: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744-748, 1992.
146. Rossi M, Sganga G, Mazzone M, et al: Cardiopulmonary bypass in man: Role of the intestine in a self-limiting inflammatory response with demonstratable bacterial translocation. Ann Thorac Surg 77:612-618, 2004.
147. O'Malley CM, Frumento RJ, Mets B, et al: Endotoxemia during left ventricular assist device insertion: Relationship between risk factors and outcome. Brit J Anaesth 92:131-133, 2004.
148. Oudemans-van Straaten HM, Jansen PGM, Hoek FJ, et al: Intestinal permeability, circulating endtoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 10:187-194, 1996.
149. Oudemans-van Straaten HM, Jansen PG-M, te Velthuis H, et al: Increase oxygen consumption after cardiac surgery is associated with inflammatory response to endotoxemia. Int Care Met 22:294-300, 1996.
150. te Velthuis H, Jansen PGM, Oudemans-van Straaten HM, et al: Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg 110:1663-1669, 1995.
151. Bennett-Guerrero E, Ayaso L, Hamitlon-Davis C, et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646-650, 1997.
152. Rothenburger M, Soeparwata R, Deng MC, et al: The impact of anti-endotoxin core antibiotics on endotoxin and cytokine release and ventilator time after cardiac surgery. J Am Coll Cardiol 38:124-130, 2001.
153. Kent BA, Mathew JP, Phillips-Bute BG, et al: Anti-endotoxin core antibodies (Endo CAB) do not influence the inflammatory response to cardiopulmonary bypass. Anesth Analg 96:SCA 21, 2003.
154. Bolke E, Jehle PM, Orth K, et al: Changes of gut barrier function during anesthesia and cardiac surgery. Angiology 52:477-482, 2001.
155. Anderson LW, Landow L, Baek L, et al: Association between gastric intramucosal pH and splanchnic endotoxin, antibody to antitoxin, and tumor necrosis factor-alpha in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210-217, 1993.
156. Edmunds HL Jr: Inflammatory responses to cardiopulmonary bypass. Ann Thorac Surg 60:S 12-6, 1998.
157. Paparella D, Yau TM, Young R: Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An Update (Review) Eur J Cardiothorac Surg 21:232-244, 2002.
158. Silva E, De Backer D, Creteur J, et al: Effects of vasoactive drugs on gastric intramucosal pH . Crit Care Med 26:1749-1758, 1998.
159. Mollhoff T, Loick HM, van Aken H, et al: Milrinone modulates endotoxemia systemic inflammation and subsequent acute phase response after cardiopulmonary bypass. Anesthesiology 90:72-80, 1999.
160. Iribe G, Yamada H, Matsunaga A, et al: Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism. Crit Care Med 28:743-748, 2000.
161. Parviarnen I, Ruokonen E, Takala J: Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intra-mucosal pH after cardiac surgery. Br J Anaesth 54:277-282, 1995.
162. Ruokonen E, Takala J, Kari A: Regional blood flow and oxygen transport in patients with low cardiac output syndrome after cardiac surgery. Crit Care Med 21:1304-1311, 1993.
163. Thoren A, Elam M, Riksten S-E: Differential effects of dopamine, dopexamine and dobutamine in jejunal mucosal perfusion early after cardiac surgery. Crit Care Med 28:2338-2343, 2000.
164. Gardenback M, Settergren G: Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary bypass. Acta Anaesth Scan 39:1066-1070, 1995.
165. Jakob SM, Ruokonen E, Takala J: Effect of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18:8-13, 2002.
166. Debaveye YA, Van den Berghe GH: Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 98:461-468, 2004.
167. Tenhunen JJ, Martkainen TJ, Uusaro A, et al: Dopexamine reverses colonic but not gastric mucosal perfusion in lethal endotoxin shock. Br J Anaesth 91:878-885, 2003.
168. Berendes E, Mollhoff T, van Aken H, et al: Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg 84:950-957, 1997.
169. Parviainen I, Ruokonen E, Takala J: Sodium nitroprusside after cardiac surgery: Systemic and splanchnic blood flow and oxygen transport. Acta Anaesth Scand 40:606-611, 1996.
170. Westphal M, Freise H, Kehrel BE, et al: Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194-200, 2004.
171. Van Haren FM, Rozendaal FM, van der Hoeven JG: The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124:2256-2260, 2003.
172. Martikainen TJ, Tenhunen JJ, Uusaro A, et al: The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756-1763, 2003.
173. Klinzing S, Simon M, Reinhart K, et al: High dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646-2650, 2003.
174. Halpenny M, Lakshmi S, O'Donnell A, et al: Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthsia 56:953-960, 2001.
175. Klein TF, Osmer C, Muller M, et al: The effect of a pre-operative infusion of Ringer's solution on splanchnic perfusion in patients undergoing coronary artery bypass grafting. Anaesthesia 57:756-760, 2002.
176. Mythen MG, Webb AR: Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 130:42-49, 1995.
177. Martinez-Pellus NE, Merino P, Bru M, et al: Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination. Int Care Med 23:1251-1257, 1997.
178. Johnston WE, Zwischenberger JB: Improving splanchnic perfusion during cardiopulmonary bypass (Editorial). Anesthesiology 92:705-707, 2000.
179. O'Dwyer C, Woodson LC, Conroy BP, et al: Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg 63:728-735, 1997.
180. O'Malley CM, Frumento RJ, Mets B, et al: Abnormal gastric tonometric variables and vasoconstrictor use after left ventricular assist device insertion. Ann Thorac Surg 75:1881-1891, 2003.
181. De Foe GR, Ross CS, Olmstead EM, et al: Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 71:769-776, 2001.
182. Fang WC, Helm RE, Krieger KH, et al: Impact of minimal hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96(Suppl II):II-194-199, 1997.
183. Moores WX, Gago O, Morris JD, et al: Serum and urinary amylase levels following pulsatile and continuous cardiopulmonary bypass. J Thorac Cardiovasc Surg 74:73-76, 1977.
184. Banbury MK, Kouchoukos NT, Allen KB, et al: Emboli capture using the Embol-X intra-aortic filter in cardiac surgery. Ann Thorac Surg 76:508-515, 2003.
185. Sack F-U, Reidenbach B, Dollner R, et al: Influence of steroids on microvascular perfusion injury of the bowel induced by extracorporeal circulation. Ann Thorac Surg 72:1321-1326, 2001.
186. Mangano DT: Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309-1317, 2002.
187. Fromes Y, Gaillard D, Ponzio D, et al: Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. European J Cardio-thorac Surg 22:527-533, 2002.
188. Poirier B, Baillot R, Bauset R, et al: [Abdominal Complications associated with cardiac surgery. Review of a contemporary surgical experience and a series done without extracorpoval circulation. (French)] Can J Surg 46:176-182, 2003.